Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine kinase 2 (TYK2) Promoter Variant in the Japanese.

MLA

Mine, Keiichiro, et al. “Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine Kinase 2 (TYK2) Promoter Variant in the Japanese.” EBioMedicine, vol. 23, Sept. 2017, pp. 46–51. EBSCOhost, https://doi.org/10.1016/j.ebiom.2017.08.012.

APA

Mine, K., Hirakawa, K., Kondo, S., Minami, M., Okada, A., Tsutsu, N., Yokogawa, Y., Hibio, Y., Kojima, F., Fujimoto, S., Kurisaki, H., Anzai, K., Yoshikai, Y., & Nagafuchi, S. (2017). Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine kinase 2 (TYK2) Promoter Variant in the Japanese. EBioMedicine, 23, 46–51. https://doi.org/10.1016/j.ebiom.2017.08.012

Chicago

Mine, Keiichiro, Kanako Hirakawa, Shiori Kondo, Masae Minami, Akira Okada, Nobutaka Tsutsu, Yasushi Yokogawa, et al. 2017. “Subtyping of Type 1 Diabetes as Classified by Anti-GAD Antibody, IgE Levels, and Tyrosine Kinase 2 (TYK2) Promoter Variant in the Japanese.” EBioMedicine 23 (September): 46–51. doi:10.1016/j.ebiom.2017.08.012.